Potential role of heterologous flavivirus immunity in preventing urban transmission of yellow fever virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Potential role of heterologous flavivirus immunity in preventing urban transmission of yellow fever virus ; volume:15 ; number:1 ; day:10 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
Nature Communications ; 15, Heft 1 (10.11.2024), 1-11, 12.2024
- Creator
-
Shinde, Divya P.
Plante, Jessica A.
Scharton, Dionna
Mitchell, Brooke
Walker, Jordyn
Azar, Sasha R.
Campos, Rafael K.
Sacchetto, Lívia
Drumond, Betânia P.
Vasilakis, Nikos
Plante, Kenneth S.
Weaver, Scott C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-54146-9
- URN
-
urn:nbn:de:101:1-2501272136555.424602132476
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shinde, Divya P.
- Plante, Jessica A.
- Scharton, Dionna
- Mitchell, Brooke
- Walker, Jordyn
- Azar, Sasha R.
- Campos, Rafael K.
- Sacchetto, Lívia
- Drumond, Betânia P.
- Vasilakis, Nikos
- Plante, Kenneth S.
- Weaver, Scott C.
- SpringerLink (Online service)
Other Objects (12)
Heterologous vaccine interventions: boosting immunity against future pandemics
Effect of prior flavivirus immunity on the adaptive response to the yellow fever 17D vaccine
Neuropathology of yellow fever autopsy cases
Yellow fever resurgence: An avoidable crisis?
Yellow fever in the diagnostics laboratory
VII. Thema 13. The campaign against yellow fever
Prevention and control of yellow fever in Africa
Yellow fever control: current epidemiology and vaccination strategies
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis
Treatment and cure of chronic viral infections and its impact on heterologous immunity
Heterologous vaccine interventions: boosting immunity against future pandemics
Effect of prior flavivirus immunity on the adaptive response to the yellow fever 17D vaccine
Neuropathology of yellow fever autopsy cases
Yellow fever resurgence: An avoidable crisis?
Yellow fever in the diagnostics laboratory
VII. Thema 13. The campaign against yellow fever
Prevention and control of yellow fever in Africa
Yellow fever control: current epidemiology and vaccination strategies
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis
Treatment and cure of chronic viral infections and its impact on heterologous immunity
Heterologous vaccine interventions: boosting immunity against future pandemics
Effect of prior flavivirus immunity on the adaptive response to the yellow fever 17D vaccine
Neuropathology of yellow fever autopsy cases
Yellow fever resurgence: An avoidable crisis?
Yellow fever in the diagnostics laboratory
VII. Thema 13. The campaign against yellow fever
Prevention and control of yellow fever in Africa
Yellow fever control: current epidemiology and vaccination strategies
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis